Israel’s CytoReason (see here previously) is partnering France’s Sanofi to identify novel therapies to treat Inflammatory Bowel Disease (IBD). Sanofi will pay CytoReason millions of dollars to use the Israeli startup’s computational AI-discovery disease model platform.

https://www.timesofisrael.com/sanofi-extends-cooperation-with-israels-cytoreason-for-bowel-disease-drug-discovery/